Zepbound is prescribed along with a reduced-calorie diet and increased exercise to: help reduce or manage weight in adults who have obesity or are overweight with at least one weight-related condition, such as type 2 diabetes, heart disease, or high blood pressure treat obstructive sleep apnea in adults who have obesity The active ingredient in Zepbound is tirzepatide
Wegovy: This is an injectable medication, usually self-administered once a week
Are there considerations for prescribing oral semaglutide in patients with cardiovascular risk factors
Whether you use a standard compounded formulation or a B12-enhanced version, the semaglutide dose itself follows the same escalation timeline
Always consult an authorized healthcare professional before making treatment decisions.
But the link, if there is one, between semaglutide and pancreatitis isnt clear-cut, and reported cases are extremely rare